j res pharm pract

Upload: fitriyahshalihah

Post on 06-Jul-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/17/2019 J Res Pharm Pract

    1/8

    J Res Pharm Pract. 2013 Apr-Jun; 2(2): 70–74.

    do: 10.4103!227"-042#.1173$%

    P&': P&'407%"0$

    Antibiotic sensitivity pattern and cost-

    effectiveness analysis of antibiotic

    therapy in an Indian tertiary care

    teaching hospital

    *hamun+um *rram,1 ar+hese Asara,1 Anne /apen 'o,1 and henatt&ohanumar 2

    Author normaton 5 Artce notes 5 'op6r+ht and cense normaton 5

    8o to:

    Abstract

    Objective:

    he purpose o ths stud6 s to ana69e the antotc senstt6 pattern o

    mcroor+ansms, to stud6 the antotc usa+e pattern, and to conduct a cost-

    eecteness ana6ss ('/A) or the antotcs prescred n a tertar6 care

    teachn+ hospta n south nda.

    Methods:

    hs prospecte stud6 as carred out n the 8enera &edcne and Pumonoo+6

    departments o the hospta or a perod o % months. he stud6 as carred out n

    three phases: A prospecte ana6ss to chec the senstt6 pattern omcroor+ansms to arous antotcs, data e.$=), Staphylococcus aureus (12.4=), and Pseudomonas (".3=).

    http://dx.doi.org/10.4103%2F2279-042X.117386http://www.ncbi.nlm.nih.gov/pubmed/?term=Sriram%20S%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Aiswaria%20V%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Aiswaria%20V%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Cijo%20AE%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Cijo%20AE%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Mohankumar%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Mohankumar%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pubmed/?term=Sriram%20S%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Aiswaria%20V%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Cijo%20AE%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Mohankumar%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed/?term=Mohankumar%20T%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/http://dx.doi.org/10.4103%2F2279-042X.117386

  • 8/17/2019 J Res Pharm Pract

    2/8

    he senstt6 pattern data o the prospecte stud6 reeaed that  E. coli as

    h+h6 senste to Amacn ("".3=), Klebsiella to Amacn ("3.$=),

     Pseudomonas to &eropenem ("7.%=), and S. pneumoniae to ?o

  • 8/17/2019 J Res Pharm Pract

    3/8

    detaed stud6 on the senstt6 pattern o mcroor+ansms, to ana69e the

    antotc usa+e pattern, and to conduct a '/A or the antotcs prescred.

    M%!&O#'

    hs prospecte cross-sectona stud6 as carred out n a 700-edded mut-

    specat6 prate corporate hospta n *outh nda durn+ % months. A patents

    hospta9ed n the 8enera &edcne and Pumonoo+6 departments or hom at

    east one antotc as prescred ere ncuded n the stud6. he stud6 protoco

    as sumtted to the ean o the stud6 hospta, 'omatore. he author9aton

    rom the ean as procured. he author as permtted to ut9e the hospta

    actes to mae a oo-up o the prescrptons n the seected department. A

    speca6 des+ned ormat as used or entern+ the preaence and senstt6 pattern o mcroor+ansms amon+ the patents durn+ the stud6 perod. A separate

    data entr6 ormat as des+ned or notn+ the pattern o antotc use.

    he stud6 as carred out n three phases. he rst phase noes a prospecte

    ana6ss to chec the senstt6 pattern o mcroor+ansms to arous antotcs

    or a % month perod. he documented data ere reeed and necessar6

    normaton such as specmen coected, or+ansm soated, and ther senstt6

     pattern ere noted don. urn+ the 2nd phase, normaton re+ardn+ the pattern

    o antotcs prescred n the Pumonoo+6 and 8enera &edcne departments

    and aso the cost o the antotcs ere otaned. urn+ the na phase, the

    senstt6 pattern o mcroor+ansms and the antotc usa+e pattern ere

    ana69ed n deta.

    A '/A as conducted 6 cacuatn+ the cost per aure aoded to nd out the

    most cost-eecte antotc n the Pumonoo+6 and 8enera &edcne

    departments. A decson tree as created on the ass o the data coected and ths

    tree as used to determne the e

  • 8/17/2019 J Res Pharm Pract

    4/8

    n sputum (7%.2=), and Proteus sp. as more common n urne ($2.3=) sampes

    B+ure 1C.

    ae 1

    *enstt6 pattern studes o antotcs

    +ure 1

    Percenta+e o mcroor+ansms ound n derent patentsE specmens (n F 7"%)

    he prospecte data reeaed that amost a the or+ansms soated ere h+h6

    senste to Amacn. t as ound that Amacn shoed the est senstt6 nS. aureus (100=), E. coli ("".3) Klebsiella speces ("3.$=), and Pseudomonas 

    ("%.3=) B+ure 2C. Proteus shoed h+h senstt6 toard +ec6cne (">.$=)

    and Actnoacter shoed h+h senstt6 toard &eropenem ("1."=) Bae 1C.

    +ure 2

    Percenta+e o mcroor+ansmsE senstt6 to derent antotcs (n F 7"%)

    Phase o the stud6 as to coect normaton on the antotc prescrn+

     pattern aon+ th the cost o antotcs rom the 8enera &edcne and

    Pumonoo+6 ards or % months perod. oer resprator6 tract nectons ere

    the maor dseases or hch antotcs ere prescred (21.2=). 'ephaosporns

    ere the maor cate+or6 o antotcs prescred (73=), ooed 6

    uoro@unoones (>3."=) B+ure 3C.

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/table/T1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F2/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/table/T1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F2/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F3/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/table/T1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F2/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/table/T1/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F2/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076908/figure/F3/

  • 8/17/2019 J Res Pharm Pract

    5/8

  • 8/17/2019 J Res Pharm Pract

    6/8

    Staphylococcus aureus (&R*A) and &ethcn-Resstant 'oa+uase-Ge+ate

    *taph6ococc (&R'oG*), out o the tota 3>0 staph6ococca soates rom

    derent cnca specmens, 14$ soates (%0.40=) ere dented as &R*A and

    4% soates (43.$0=) ere screened as &R'oG*. A soates o &R*A and

    &R'oG* ere mut-dru+ resstant. Antotc resstance pattern o these soatesas h+h a+anst pencn, hereas a the &R*A strans ere resstant to

     pencn and o

  • 8/17/2019 J Res Pharm Pract

    7/8

    Footnotes

    'ource of 'upport: G

    Conflict of Interest: Gone decared.

    "%F%"%C%'

    1. tte P, atson , &or+an *, amson . Antotc prescrn+ and

    admssons th maor suppurate compcatons o resprator6 tract nectons: Adata na+e stud6. Kr J 8en Pract. 2002;>2:1$7–"0. 1"3. BP&' ree artceC

    BPu&edC

    2. Kraden R. *ur+ca antotc proph6a0–7. BP&' ree artceC BPu&edC

    %. 'ooe J. Pharmacoeconomcs. n: Ro+er , 'e /, edtors. A e%:7%–$. BPu&edC

    ". Pereen , &ad A, Mnaa *, Ga9 , *ehar *, Ahmad *, et a. Preaence and

    antmcroa susceptt6 pattern o methcn-resstant Staphylococcus aureus 

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314237/http://www.ncbi.nlm.nih.gov/pubmed/12030660http://www.medscape.com/viewarticle/722032http://www.medscape.com/viewarticle/722032http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449013/http://www.ncbi.nlm.nih.gov/pubmed/8516976http://www.ncbi.nlm.nih.gov/pubmed/19223418http://www.ncbi.nlm.nih.gov/pubmed/20622384http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314237/http://www.ncbi.nlm.nih.gov/pubmed/12030660http://www.medscape.com/viewarticle/722032http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449013/http://www.ncbi.nlm.nih.gov/pubmed/8516976http://www.ncbi.nlm.nih.gov/pubmed/19223418http://www.ncbi.nlm.nih.gov/pubmed/20622384

  • 8/17/2019 J Res Pharm Pract

    8/8

    and coa+uase-ne+ate *taph6ococc n Raapnd, Pastan. Kr J &ed &ed

    Res. 2013;3:1"$–20".

    10. Hoo+endoorn &, *maru++e &, *toern+h //, an Rossum *,

    amnc< KJ, hsen *. Preaence o antotc resstance o the commensaora n dutch nursn+ homes. J Am &ed r Assoc. 2013;14:33%–". BPu&edC

    11. aoe , Kas , 'astou< A&, *caera A, eorer J. /ecteness and

    cost-eecteness o antotc treatments or communt6 ac@ured pneumona

    ('AP) and acute e